[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369477-105":59,"doc-detail-369477-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","enhanced-expression-of-mitochondrial-magmas-protein-in-ovarian-carcinomas-magmas-inhibition-facilitates-antitumour-effects-signifying-a-novel-approach-for-ovarian-cancer-treatment","Enhanced Expression of Mitochondrial Magmas Protein in Ovarian Carcinomas - Magmas Inhibition Facilitates Antitumour Effects, Signifying a Novel Approach for Ovarian Cancer Treatment","","Mitochondrial-associated granulocyte macrophage colony-stimulating factor (Magmas) is a mitochondrial inner-membrane protein involved in scavenging reactive oxygen species (ROS). Ovarian cancer is driven by ROS production within the tumour microenvironment and shows genomic instability, prompting evaluation of Magmas function. The study characterizes Magmas expression in human tumours and tests BT#9, a novel small-molecule Magmas inhibitor. BT#9 increases ROS, reduces mitochondrial membrane permeability and respiration, suppressing proliferation and migration in vitro, while oral dosing limits tumour growth and spread in vivo and improves survival without peritoneal organ effects.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/enhanced-expression-of-mitochondrial-magmas-protein-in-ovarian-carcinomas-magmas-inhibition-facilitates-antitumour-effects-signifying-a-novel-approach-for-ovarian-cancer-treatment/369477/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/enhanced-expression-of-mitochondrial-magmas-protein-in-ovarian-carcinomas-magmas-inhibition-facilitates-antitumour-effects-signifying-a-novel-approach-for-ovarian-cancer-treatment/369477.png","ImageObject",300,407,{"name":92,"@type":93},"Sophia Brooks","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does Magmas play in cellular systems relevant to ovarian cancer?","Question",{"text":112,"@type":113},"Magmas is a mitochondrial inner-membrane protein that scavenges reactive oxygen species (ROS), influencing oxidative stress in cellular systems and linking to ovarian cancer biology through ROS in the tumour microenvironment.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the inhibitor BT#9 affect ovarian cancer cells and their mitochondria?",{"text":117,"@type":113},"BT#9 inhibition of Magmas enhances ROS production and reduces mitochondrial membrane permeability, basal respiration, mitochondrial ATP production, and cancer cell functions such as proliferation and migration in vitro.",{"name":119,"@type":110,"acceptedAnswer":120},"What outcomes were observed with oral BT#9 treatment in vivo?",{"text":121,"@type":113},"Oral administration of BT#9 significantly reduced tumour growth and spread in mice and improved survival, without affecting peritoneal organs.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369477,1790800086,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084925636,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Article  \nEnhanced Expression of Mitochondrial Magmas Protein in Ovarian Carcinomas: Magmas Inhibition Facilitates Antitumour Effects, Signifying a Novel Approach for Ovarian  \nCancer Treatment  \nAli Raza 1,2, Ashfaqul Hoque 3, Rodney Luwor 1,2,4,†, Ruth M. Escalona 1,5,6,†, Jason Kelly 1, Revati Sharma 1, Fadi Charchar 2, Simon Chu 5,6, Mary K. Short 7, Paul T. Jubinsky 7, George Kannourakis 1,2 and  \nNuzhat Ahmed 1,2,5,6,8,9, *  \nAcademic Editor: Alexander  \nE. Kalyuzhny  \nReceived: 15 March 2025  \nRevised: 13 April 2025  \nAccepted: 26 April 2025  \nPublished: 29 April 2025  \nCitation: Raza, A.; Hoque, A.; Luwor, R.; Escalona, R.M.; Kelly, J.; Sharma, R.; Charchar, F.; Chu, S.; Short, M.K.; Jubinsky, P.T.; et al. Enhanced Expression of Mitochondrial Magmas Protein in Ovarian Carcinomas:  \nMagmas Inhibition Facilitates Antitumour Effects, Signifying a Novel Approach for Ovarian Cancer Treatment. Cells 2025, 14, 655 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)cells14090655  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Fiona Elsey Cancer Research Institute, Ballarat, VIC 3353, Australia; [ali@fecri.org.au](ali@fecri.org.au) (A.R.); [rodney@fecri.org.au](rodney@fecri.org.au) (R.L.); [ruth@fecri.org.au](ruth@fecri.org.au) (R.M.E.); [jason@fecri.org.au](jason@fecri.org.au) (J.K.); [revati@fecri.org.au](revati@fecri.org.au) (R.S.); [george@fecri.org.au](george@fecri.org.au) (G.K.)  \n2 Institute of Innovation, Science and Sustainability, Federation University Australia, Health Innovation and Transformation Center, Mount Helen Campus, Ballarat, VIC 3050, Australia; [f.charchar@federation.edu.au](f.charchar@federation.edu.au)  \n3 St Vincent’s Institute of Medical Research, Fitzroy, VIC 3065, Australia; [ahoque@svi.edu.au](ahoque@svi.edu.au)  \n4 Department of Surgery, Faculty of Medicine, Dentistry and Health Sciences, Royal Melbourne Hospital, Melbourne, VIC 3050, Australia  \n5 Centre for Endocrinology and Reproductive Health, Hudson Institute of Medical Research, Clayton, VIC 3168, Australia; [simon.chu@hudson.org.au](simon.chu@hudson.org.au)  \n6 Department of Molecular & Translational Science, Faculty of Medicine, Nursing and Health Sciences, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC 3168, Australia  \n7 Developmental and Molecular Biology, Albert Einstein College of Medicine, New York, NY 10461, USA; [mshortstop@frontier.com](mshortstop@frontier.com) (M.K.S.); [pajubins@montefiore.org](pajubins@montefiore.org) (P.T.J.)  \n8 Department of Obstetrics and Gynaecology, Faculty of Medicine, Dentistry and Health Sciences, Royal Women’s Hospital, University of Melbourne, Parkville, VIC 3050, Australia  \n9 Department of Surgery, Faculty of Medicine, Dentistry and Health Sciences, St Vincent Hospital, University of Melbourne, Fitzroy, VIC 3065, Australia  \n* [Correspondence: nuzhata@unimelb.edu.au or nuzhat@fecri.org.au](Correspondence: nuzhata@unimelb.edu.au or nuzhat@fecri.org.au)[ ](Correspondence: nuzhata@unimelb.edu.au or nuzhat@fecri.org.au)† These authors contributed equally to this work.  \nAbstract: Mitochondrial-associated granulocyte macrophage colony-stimulating factor (Magmas) is a unique protein located in the inner membrane of mitochondria, with an active role in scavenging reactive oxygen species (ROS) in cellular systems. Ovarian cancer (OC), one of the deadliest gynaecological cancers, is characterised by genomic instability, affected by ROS production in the tumour microenvironment. This manuscript discusses the role of Magmas and efficacy of its novel small molecule inhibitor BT\\#9 in OC progression, metastasis, and chemoresistance. Magmas expression levels we","cbCaikvTMNQLgoj3","https://ap.wps.com/l/cbCaikvTMNQLgoj3","pdf",15399647,32,"English","# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"What role does Magmas play in cellular systems relevant to ovarian cancer?\",\"answer\":\"Magmas is a mitochondrial inner-membrane protein that scavenges reactive oxygen species (ROS), influencing oxidative stress in cellular systems and linking to ovarian cancer biology through ROS in the tumour microenvironment.\"},{\"question\":\"How does the inhibitor BT#9 affect ovarian cancer cells and their mitochondria?\",\"answer\":\"BT#9 inhibition of Magmas enhances ROS production and reduces mitochondrial membrane permeability, basal respiration, mitochondrial ATP production, and cancer cell functions such as proliferation and migration in vitro.\"},{\"question\":\"What outcomes were observed with oral BT#9 treatment in vivo?\",\"answer\":\"Oral administration of BT#9 significantly reduced tumour growth and spread in mice and improved survival, without affecting peritoneal organs.\"}]","Enhanced Expression of Mitochondrial Magmas Protein in Ovarian Carcinomas - Magmas Inhibition Facilitates Antitumour Effects, Signifying a Novel Approach for Ovarian Cancer Treatment | PDF",1790182907,81,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/378efd799bc995b70b30277405a09482.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a1a78762540eda07a05d97d09f811e16.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e612adbd1f5470316f40535dac37294a.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/49ca70d5ddf8b4d77f7a45958a764388.webp",980,1385]